SRX 0.00% 17.5¢ sierra rutile holdings limited

bargain bargain

  1. 168 Posts.
    US big company (Cephalon) takeover bid last year at $4.8 prove the credibility of Sirtex liver cancer treatment tech. There is not much competitor on its product either. Only one other company Nordion, is developing similar drug.

    At $3 marks, SRX looks cheap. I'm sure Cephalon is watching and may put another offer on the table.

    Comments welcome.

    I hold lots.
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.